Clinical Nuclear Medicine · 2009 · 13 citations · 9 references
MedicineOncologySurgeryEndocrine OncologyMetastasisRadionuclide TherapyBone MetastasisMetastatic Bone DiseaseRadioiodine TherapyThyroid CancerThyroid DisordersThyroid SurgeryFemur FracturesFollicular Thyroid Carcinoma SurgeryFollicular Thyroid NeoplasmsIodine-131 ScintigraphyIodine-131 Therapy ImagingMetastatic Tumors To The ThyroidPelvic MetastasesPostoperative Thyrotoxicosis
We present a case of functioning metastatic follicular thyroid carcinoma (FTC) causing severe thyrotoxicosis despite four years 12 iodine-131 therapies (1.461 Ci cumulatively). Initially, the patient had ostalgia and fracture in the right femur. Surgery-confirmed metastatic bone FTC and thyroidectomy-confirmed FTC. One month later, iodine-131 treatment commenced. During the follow-up, different metastatic sites showed different outcomes. Lung metastases disappeared, a thigh metastasis persisted, a new metastasis in the head occurred and pelvic metastases deteriorated into a huge mass elevating thyroglobulin and causing thyrotoxicosis within 3 months. Presurgical PET/CT also demonstrated the massiveness of the pelvic metastases. Thyrotoxicosis disappeared after surgical removal of the pelvic lesion.
9
Akira Miyauchi, Yuuki Takamura, Yasuhiro Ito et al. · The Journal of Clinical Endocrinology & Metabolism · 2008 · 47 citations
Medicine, Endocrinology, Oncology +15
Survival Analysis of 19 Patients with Toxic Thyroid Carcinoma
C. Als, Peter Gedeon, Helmuth Rösler et al. · The Journal of Clinical Endocrinology & Metabolism · 2002 · 45 citations
Medicine, Nuclear Medicine, Oncology +17